New York Medical College: GLP-1 Study Finds Survival Benefits Outweigh Cognitive Risks for Diabetics
August 05, 2026
August 05, 2026
VALHALLA, New York, Aug. 5 -- New York Medical College issued the following news:
* * *
GLP-1 Study Finds Survival Benefits Outweigh Cognitive Risks for Diabetics
Researchers Found That Age Plays an Important Role in the Risk-Benefit Balance of GLP-1 Analogue Treatment
-
The decreased risk of death for patients with type 2 diabetes treated with GLP-1 analogues outweighs the increased risk of cognitive impairment, though age plays a . . .
* * *
GLP-1 Study Finds Survival Benefits Outweigh Cognitive Risks for Diabetics
Researchers Found That Age Plays an Important Role in the Risk-Benefit Balance of GLP-1 Analogue Treatment
-
The decreased risk of death for patients with type 2 diabetes treated with GLP-1 analogues outweighs the increased risk of cognitive impairment, though age plays a . . .